| Product Code: ETC6770378 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Colombia saw significant import shipments of non-alcoholic steatohepatitis (NASH) biomarkers from top exporting countries including South Korea, China, Germany, UK, and the USA. Despite a negative compound annual growth rate (CAGR) of -6.0% from 2020 to 2024, the market experienced a sharp decline in growth from 2023 to 2024 at -48.46%. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting potential opportunities for market players to explore in the evolving landscape of NASH diagnostics and treatments in Colombia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Colombia |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of NASH |
4.2.3 Technological advancements in biomarker development for NASH |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for NASH biomarker testing in Colombia |
4.3.2 High cost associated with developing and commercializing biomarkers |
4.3.3 Regulatory challenges in gaining approvals for NASH biomarkers |
5 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F |
6.1.4 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F |
6.1.5 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F |
6.1.6 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.4 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of research studies conducted on NASH biomarkers in Colombia |
8.2 Adoption rate of NASH biomarker testing by healthcare providers |
8.3 Investment in RD for NASH biomarkers in the Colombian market |
9 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Colombia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |